These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20567176)

  • 21. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M; He P; Fu J
    J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pravastatin Protects Cytotrophoblasts from Hyperglycemia-Induced Preeclampsia Phenotype.
    Pantho AF; Mohamed S; Govande JV; Rane R; Vora N; Kelso KR; Kuehl TJ; Lindheim SR; Uddin MN
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy.
    Aldika Akbar MI; Herdiyantini M; Aryananda RA; CIninta N; Wardhana MP; Gumilar KE; Wicaksono B; Ernawati ; Sulistyono A; Aditiawarman ; Joewono HT; Nadir Abdullah ; Dekker G; Dachlan EG; Dikman Angsar M
    Hypertens Pregnancy; 2018 Nov; 37(4):175-181. PubMed ID: 30277426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
    Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
    DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placental soluble fms-like tyrosine-kinase-1 (sFlt-1) in pregnant women with preeclampsia.
    Dimitrakova ED; Dimitrakov JD; Karumanchi SA; Pehlivanov BK; Milchev NP; Dimitrakov DI
    Folia Med (Plovdiv); 2004; 46(1):19-21. PubMed ID: 15362808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different Effects of Pravastatin on Preeclampsia-like Symptoms in Different Mouse Models.
    Huai J; Yang Z; Yi YH; Wang GJ
    Chin Med J (Engl); 2018 Feb; 131(4):461-470. PubMed ID: 29451152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.
    Szalai G; Xu Y; Romero R; Chaiworapongsa T; Xu Z; Chiang PJ; Ahn H; Sundell B; Plazyo O; Jiang Y; Olive M; Wang B; Jacques SM; Qureshi F; Tarca AL; Erez O; Dong Z; Papp Z; Hassan SS; Hernandez-Andrade E; Than NG
    PLoS One; 2014; 9(11):e110867. PubMed ID: 25393290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
    Ren Z; Cui N; Zhu M; Khalil RA
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
    Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
    Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion.
    Hastie R; Brownfoot FC; Pritchard N; Hannan NJ; Cannon P; Nguyen V; Palmer K; Beard S; Tong S; Kaitu'u-Lino TJ
    Hypertension; 2019 Mar; 73(3):659-670. PubMed ID: 30636550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of complement component C1q in the onset of preeclampsia in mice.
    Singh J; Ahmed A; Girardi G
    Hypertension; 2011 Oct; 58(4):716-24. PubMed ID: 21859968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia.
    Pereira DA; Sandrim VC; Palei ACT; Tanus-Santos JE; Belo VA; Cavalli RC; Luizon MR
    Pregnancy Hypertens; 2019 Oct; 18():137-140. PubMed ID: 31610400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of maternal pravastatin therapy on adverse sensorimotor outcomes of the offspring in a murine model of preeclampsia.
    Carver AR; Tamayo E; Perez-Polo JR; Saade GR; Hankins GD; Costantine MM
    Int J Dev Neurosci; 2014 Apr; 33():33-40. PubMed ID: 24287098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preeclampsia pravastatin early VS late treatment: Effects on oxidative stress and vascular reactivity.
    Ramírez Sanchez FA; Madrigal Aguilar D; Tufiño C; Castro García S; Bobadilla Lugo RA
    Pregnancy Hypertens; 2024 Mar; 35():96-102. PubMed ID: 38306739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.